Thermo Fisher Scientific (TMO) Competitors $426.65 +7.95 (+1.90%) Closing price 03:59 PM EasternExtended Trading$424.10 -2.55 (-0.60%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TMO vs. MEDP, A, AMN, DHR, HAE, MCK, QGEN, WST, MTD, and WATShould you be buying Thermo Fisher Scientific stock or one of its competitors? The main competitors of Thermo Fisher Scientific include Medpace (MEDP), Agilent Technologies (A), AMN Healthcare Services (AMN), Danaher (DHR), Haemonetics (HAE), McKesson (MCK), Qiagen (QGEN), West Pharmaceutical Services (WST), Mettler-Toledo International (MTD), and Waters (WAT). These companies are all part of the "medical" sector. Thermo Fisher Scientific vs. Its Competitors Medpace Agilent Technologies AMN Healthcare Services Danaher Haemonetics McKesson Qiagen West Pharmaceutical Services Mettler-Toledo International Waters Medpace (NASDAQ:MEDP) and Thermo Fisher Scientific (NYSE:TMO) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, dividends, earnings, analyst recommendations, profitability, institutional ownership, valuation and risk. Does the media prefer MEDP or TMO? In the previous week, Thermo Fisher Scientific had 55 more articles in the media than Medpace. MarketBeat recorded 62 mentions for Thermo Fisher Scientific and 7 mentions for Medpace. Thermo Fisher Scientific's average media sentiment score of 1.21 beat Medpace's score of 0.93 indicating that Thermo Fisher Scientific is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Medpace 5 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Thermo Fisher Scientific 45 Very Positive mention(s) 6 Positive mention(s) 7 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive Which has higher earnings and valuation, MEDP or TMO? Thermo Fisher Scientific has higher revenue and earnings than Medpace. Medpace is trading at a lower price-to-earnings ratio than Thermo Fisher Scientific, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMedpace$2.11B4.39$404.39M$13.1024.62Thermo Fisher Scientific$42.88B3.76$6.34B$17.0525.02 Do institutionals & insiders hold more shares of MEDP or TMO? 78.0% of Medpace shares are held by institutional investors. Comparatively, 89.2% of Thermo Fisher Scientific shares are held by institutional investors. 20.3% of Medpace shares are held by insiders. Comparatively, 0.3% of Thermo Fisher Scientific shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Which has more volatility & risk, MEDP or TMO? Medpace has a beta of 1.47, meaning that its stock price is 47% more volatile than the S&P 500. Comparatively, Thermo Fisher Scientific has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500. Do analysts recommend MEDP or TMO? Medpace presently has a consensus price target of $344.82, suggesting a potential upside of 6.92%. Thermo Fisher Scientific has a consensus price target of $603.05, suggesting a potential upside of 41.35%. Given Thermo Fisher Scientific's stronger consensus rating and higher possible upside, analysts clearly believe Thermo Fisher Scientific is more favorable than Medpace.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Medpace 0 Sell rating(s) 11 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.21Thermo Fisher Scientific 0 Sell rating(s) 4 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 2.80 Is MEDP or TMO more profitable? Medpace has a net margin of 19.31% compared to Thermo Fisher Scientific's net margin of 15.19%. Medpace's return on equity of 54.36% beat Thermo Fisher Scientific's return on equity.Company Net Margins Return on Equity Return on Assets Medpace19.31% 54.36% 20.81% Thermo Fisher Scientific 15.19%17.15%8.47% SummaryThermo Fisher Scientific beats Medpace on 10 of the 16 factors compared between the two stocks. Get Thermo Fisher Scientific News Delivered to You Automatically Sign up to receive the latest news and ratings for TMO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TMO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TMO vs. The Competition Export to ExcelMetricThermo Fisher ScientificMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$158.06B$6.70B$5.46B$20.45BDividend Yield0.41%1.21%5.24%3.72%P/E Ratio25.0224.9227.0127.80Price / Sales3.7684.07380.1449.81Price / Cash13.9421.4826.2118.22Price / Book3.294.787.994.58Net Income$6.34B$173.18M$3.16B$982.91M7 Day Performance1.26%2.66%3.69%1.31%1 Month Performance6.13%-0.49%2.91%4.85%1 Year Performance-20.40%18.78%34.30%14.09% Thermo Fisher Scientific Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TMOThermo Fisher Scientific4.9923 of 5 stars$426.65+1.9%$603.05+41.3%-22.5%$158.06B$42.88B25.02125,000Positive NewsAnalyst ForecastMEDPMedpace4.4512 of 5 stars$312.45+0.6%$344.82+10.4%-20.8%$8.98B$2.16B23.855,900AAgilent Technologies4.7243 of 5 stars$117.92-1.0%$140.92+19.5%-5.7%$33.50B$6.51B29.1218,100Positive NewsAnalyst ForecastAMNAMN Healthcare Services4.3218 of 5 stars$20.97+0.4%$32.08+53.0%-56.2%$802.73M$2.98B-4.842,968News CoverageDHRDanaher4.8864 of 5 stars$197.07-0.9%$248.61+26.2%-16.6%$141.04B$23.82B38.2763,000Positive NewsAnalyst ForecastHAEHaemonetics4.8803 of 5 stars$74.92+1.5%$96.80+29.2%-11.7%$3.60B$1.36B22.633,023Positive NewsMCKMcKesson4.6272 of 5 stars$728.52+0.4%$696.42-4.4%+25.1%$91.15B$359.05B28.2075,000Positive NewsAnalyst UpgradeQGENQiagen3.8869 of 5 stars$47.95+0.4%$49.40+3.0%+18.8%$10.66B$1.98B120.225,765Dividend AnnouncementWSTWest Pharmaceutical Services4.7576 of 5 stars$217.78-0.5%$320.00+46.9%-31.3%$15.65B$2.89B34.1910,600MTDMettler-Toledo International4.3297 of 5 stars$1,170.88-1.2%$1,300.36+11.1%-11.7%$24.33B$3.87B29.2018,000Positive NewsAnalyst ForecastWATWaters4.5305 of 5 stars$348.87-1.0%$388.00+11.2%+21.0%$20.76B$2.96B31.668,200Trending NewsAnalyst Upgrade Related Companies and Tools Related Companies Medpace Alternatives Agilent Technologies Alternatives AMN Healthcare Services Alternatives Danaher Alternatives Haemonetics Alternatives McKesson Alternatives Qiagen Alternatives West Pharmaceutical Services Alternatives Mettler-Toledo International Alternatives Waters Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:TMO) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe day and month stocks are most likely to crash nextGood News for Stocks 50-year Wall Street veteran, Marc Chaikin is stepping forward to share why history giv...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Thermo Fisher Scientific Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Thermo Fisher Scientific With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.